⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Quant Large & Mid Cap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Quant MF | HDFC MF |
| Category | Equity - Large & Mid Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹133.64 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | NIFTY LargeMidcap 250 - TRI | BSE Health Care - TRI |
| Fund Manager | Sandeep Tandon | Nikhil Mathur |
| Inception | 07 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | 4.49% | 22.64% |
| 3Y | 15.05% | 30.41% |
| 5Y | 14.97% | — |
| Since Inception | 17.42% | 29.15% |
| Risk | ||
| 16.95 | 14.07 | |
| 1.03 | 0.59 | |
| 0.49 | 1.59 | |
| 2.94 | 21.67 | |
| 1.01 | 3.48 | |
| -10.74% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.23% | 1.03% |
| Exit Load | 1% on or before 15D, Nil after 15D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹1,000 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Quant MF98%
HDFC MF98%
2.1%Only 2.1% of holdings by weight are common between Quant MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingQuant MFHDFC MF
Glenmark Pharmaceuticals Ltd.3.98%2.09%
Category context: Equity vs Equity. Open the full Screener →